StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Clonidinhydrochlorid

Clonidine Hydrochloride

HCID 20179
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
4205-91-8
Standard-SMILES
Cl.Clc1cccc(Cl)c1NC1=NCCN1
InChIKey
ZNIFSRGNXRYGHF-UHFFFAOYSA-N
Summenformel
C9H10Cl3N3
Durchschnittliche Molmasse
266,6 g/mol
Monoisotopische Masse
264,99403

Überblick

Clonidine hydrochloride is a dichlorobenzene.

Namen und Bezeichner

Bevorzugter Name
Clonidine Hydrochloride
IUPAC
N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride
Lokaler Name
Clonidinhydrochlorid
Englischer Name
Clonidine hydrochloride
Summenformel
C9H10Cl3N3
Molmasse
266.55

Namen und Synonyme

CLONIDINE HYDROCHLORIDE4205-91-8Clonidine HClKapvayDuraclonJenlogaST-155Onyda XRDTXSID8044670Clonidine HCICatapres tts 1Catapres tts 2
Weitere Namen anzeigen
dcai2-(2,6-DICHLOROANILINO)-2-IMIDAZOLINE HYDROCHLORIDEDIXARIThemitonNeuclonatensinacapresinclofelinhaemiton
NSC-7566992-((2,6-Dichlorophenyl)imino)imidazolidine monohydrochlorideW76I6XXF06Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-, monohydrochlorideDTXCID60246702-[(2,6-Dichlorophenyl)imino]imidazolidine monohydrochlorideCatapres tts 3Catapres p.l.

Datenbank-Bezeichner

CAS
4205-91-8
PubChem CID
20179
DTXSID
DTXSID8044670
ChEMBL
CHEMBL1705
ChEBI
CHEBI:3758
UNII

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
36,4 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
1
Frei drehbare Bindungen
2
Schwere Atome
15
Formalladung
0
Komplexität
222

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Adrenergic alpha-2 Receptor Agonists

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section143.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
312 °C · 312 °C
storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: 50 mg/mL, clear, colorless
Aggregatzustand
solid
Farbe
white
PH
pH(50g/l, 25℃) : 3.5~6.0
Wasserlöslichkeit
Soluble in water (50 mg/ml), DMSO (75 mM), methanol, chloroform (slightly), and dehydrated alcohol.
Merck
14 · 14,2390
BRN
4163525 · 4163525
BCS Class

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P260, P264, P270, P271, P284, P301+P316, P304+P340, P316, P320, P321, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 49 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, monohydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-, monohydrochloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (100%)

Toxikologische Informationen

Treatment · 1 Eintrag

There is no specific antidote for clonidine overdosage. Clonidine overdosage may result in the rapid development of CNS depression; therefore, induction of vomiting with ipecac syrup is not recommended. Gastric lavage may be indicated following recent and/or large ingestions. Administration of activated charcoal and/or a cathartic may be beneficial. Supportive care may include atropine sulfate for bradycardia, intravenous fluids and/or vasopressor agents for hypotension and vasodilators for hypertension. Naloxone may be a useful adjunct for the management of clonidine-induced respiratory depression, hypotension and/or coma; blood pressure should be monitored since the administration of naloxone has occasionally resulted in paradoxical hypertension. Tolazoline administration has yielded inconsistent results and is not recommended as first-line therapy. (L1712)

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Hepatic. Metabolized via minor pathways. The major metabolite, <i>p</i>-hydroxyclonidine, is present in concentrations less than 10% of those of unchanged clonidine in urine. Four metabolites have been detected, but only <i>p</i>-hydroxyclonidine has been identified. Half Life: 6-20 hours; 40-60% is excreted in urine unchanged, 20% is excreted in feces. Less than 10% is excreted by <i>p</i>-hydroxyclonidine.

FDA Pharmacological Classification · 4 Einträge

CLONIDINE HCI

Central alpha-2 Adrenergic Agonist [EPC]; Adrenergic alpha2-Agonists [MoA]

CLONIDINE HYDROCHLORIDE

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

MeSH Pharmacological Classification · 4 Einträge

Compounds capable of relieving pain without the loss of CONSCIOUSNESS.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.

Verwendung und Herstellung

Uses · 1 Eintrag

May be used as an adjunct in the treatment of hypertension, as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone, for differential diagnosis of pheochromocytoma in hypertensive patients, prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD).

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 716609
HRID 716609als Edukt
Reaktionsgleichung von HRID 1527648
HRID 1527648als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
W76I6XXF06
EC Number
224-121-5
1 · 1 (LogP), 3 (CLogP)
Stabilität
Hygroscopic
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C9H9Cl2N3.ClH/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9;/h1-3H,4-5H2,(H2,12,13,14);1H
InChIKey
GLEWMLFXCSBZLK-UHFFFAOYSA-N
SMILES
C1(=C(Cl)C=CC=C1Cl)NC1=NCCN1.Cl
CAS Datenbank
4205 · 4205-91-8(CAS DataBase Reference)
EPA chemische Informationen
1 H-Imidazol-2-amine, · 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, hydrochloride (1:1) (4205-91-8)
Exposure RoutesWell absorbed following oral administration. Bioavailability following chronic administration is approximately 65%.
Toxicity Summary · 1 Eintrag

Clonidine acts as an agonist at presynaptic alpha(2)-receptors in the nucleus tractus solitarius of the medulla oblongata. Stimulation of these receptors results in the supression of efferent sympathetic pathways and the subsequent decrease in blood pressure and vascular tone in the heart, kidneys, and peripheral vasculature. Clonidine is also a partial agonist at presynaptic alpha(2)-adrenergic receptors of peripheral nerves in vascular smooth muscle.

Signs and SymptomsSymptoms of overdose include constriction of pupils of the eye, drowsiness, high blood pressure followed by a drop in pressure, irritability, low body temperature, slowed breathing, slowed heartbeat, slowed reflexes, and weakness.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Clonidine hydrochloride

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 150 mg/kg (oral, rat) LD50: 30 mg/kg (oral, dog)

Sicherheitsdaten

F
10
wgk
3
ridadr
UN 2811 6.1/PG 1
hs_code
2933290000
RTECS-Nr.
NJ2490000
risk_code
25-26
Toxizität
LD50 in mice, rats (mg/kg): 328, 270 orally; 18, 29 i.v. (Walland)
hazard_code
T+
safety_code
22-26-28-36/37/39-45
hazard_class
6.1(b)
packing_group
III
Speicherklasse
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
Hazard Classifications
Acute Tox. 1 InhalationAcute Tox. 3 Oral
Anwendungen · 1 Eintrag

VerwendenClonidine hydrochloride tablets are indicated in the treatment of hypertension. It has found new uses, including treatment of some types of neuropathic pain, opioid detoxification, sleep hyperhidrosis, anaesthetic use, and off-label, to counter the side effects of stimulant medications such as methylphenidate or amphetamine. It is becoming a more accepted treatment for insomnia, as well as for relief of menopausal symptoms. Clonidine(4205-91-8) is increasingly used in conjunction with stimulants to treat attention-deficit hyperactivity disorder (ADHD).

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2,6-DichloranilinMethyljodidWasserstoffthiocyanate1,2-DiaminoethanEthanolDichlorphenamide bulk powderClonidinHydrogenchloridWasser